Your browser doesn't support javascript.
loading
Effects of cabozantinib on pain and narcotic use in patients with castration-resistant prostate cancer: results from a phase 2 nonrandomized expansion cohort.
Basch, Ethan; Autio, Karen A; Smith, Matthew R; Bennett, Antonia V; Weitzman, Aaron L; Scheffold, Christian; Sweeney, Christopher; Rathkopf, Dana E; Smith, David C; George, Daniel J; Higano, Celestia S; Harzstark, Andrea L; Sartor, A Oliver; Gordon, Michael S; Vogelzang, Nicholas J; de Bono, Johann S; Haas, Naomi B; Corn, Paul G; Schimmoller, Frauke; Scher, Howard I.
Affiliation
  • Basch E; Cancer Outcomes Research Program, Lineberger Cancer Center, University of North Carolina, Chapel Hill, NC, USA. Electronic address: Ebasch@med.unc.edu.
  • Autio KA; Genitourinary Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weil Cornell Medical College, New York, NY, USA.
  • Smith MR; Genitourinary Oncology Program, Massachusetts General Hospital, Boston, MA, USA.
  • Bennett AV; Cancer Outcomes Research Program, Lineberger Cancer Center, University of North Carolina, Chapel Hill, NC, USA.
  • Weitzman AL; Clinical Development, Exelixis, Inc., South San Francisco, CA, USA.
  • Scheffold C; Clinical Development, Exelixis, Inc., South San Francisco, CA, USA.
  • Sweeney C; Genitourinary Oncology, Dana Farber Cancer Institute, Boston, MA, USA.
  • Rathkopf DE; Genitourinary Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
  • Smith DC; Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
  • George DJ; Genitourinary Medical Oncology, Duke University Medical Center, Durham, NC, USA.
  • Higano CS; Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA, USA.
  • Harzstark AL; Urologic Surgery and Oncology, University of California San Francisco, San Francisco, CA, USA.
  • Sartor AO; Tulane Cancer Center, Tulane University, New Orleans, LA, USA.
  • Gordon MS; Pinnacle Oncology Hematology, Scottsdale, AZ, USA.
  • Vogelzang NJ; Medical Oncology, Comprehensive Cancer Centers of Nevada, Las Vegas, NV, USA.
  • de Bono JS; Drug Development Unit, Royal Marsden Hospital, Sutton, Surrey, UK.
  • Haas NB; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.
  • Corn PG; Department of Genitourinary Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA.
  • Schimmoller F; Clinical Development, Exelixis, Inc., South San Francisco, CA, USA.
  • Scher HI; Genitourinary Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weil Cornell Medical College, New York, NY, USA.
Eur Urol ; 67(2): 310-8, 2015 Feb.
Article in En | MEDLINE | ID: mdl-24631409
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pain / Pyridines / Protein Kinase Inhibitors / Prostatic Neoplasms, Castration-Resistant / Analgesics, Opioid / Anilides / Antineoplastic Agents Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Risk_factors_studies Aspects: Patient_preference Limits: Aged / Humans / Male / Middle aged Country/Region as subject: America do norte / Europa Language: En Journal: Eur Urol Year: 2015 Document type: Article Country of publication: Switzerland
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pain / Pyridines / Protein Kinase Inhibitors / Prostatic Neoplasms, Castration-Resistant / Analgesics, Opioid / Anilides / Antineoplastic Agents Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Risk_factors_studies Aspects: Patient_preference Limits: Aged / Humans / Male / Middle aged Country/Region as subject: America do norte / Europa Language: En Journal: Eur Urol Year: 2015 Document type: Article Country of publication: Switzerland